Combining information from common type 2 diabetes risk polymorphisms improves disease prediction
- PMID: 17020404
- PMCID: PMC1584415
- DOI: 10.1371/journal.pmed.0030374
Combining information from common type 2 diabetes risk polymorphisms improves disease prediction
Abstract
Background: A limited number of studies have assessed the risk of common diseases when combining information from several predisposing polymorphisms. In most cases, individual polymorphisms only moderately increase risk (approximately 20%), and they are thought to be unhelpful in assessing individuals' risk clinically. The value of analyzing multiple alleles simultaneously is not well studied. This is often because, for any given disease, very few common risk alleles have been confirmed.
Methods and findings: Three common variants (Lys23 of KCNJ11, Pro12 of PPARG, and the T allele at rs7903146 of TCF7L2) have been shown to predispose to type 2 diabetes mellitus across many large studies. Risk allele frequencies ranged from 0.30 to 0.88 in controls. To assess the combined effect of multiple susceptibility alleles, we genotyped these variants in a large case-control study (3,668 controls versus 2,409 cases). Individual allele odds ratios (ORs) ranged from 1.14 (95% confidence interval [CI], 1.05 to 1.23) to 1.48 (95% CI, 1.36 to 1.60). We found no evidence of gene-gene interaction, and the risks of multiple alleles were consistent with a multiplicative model. Each additional risk allele increased the odds of type 2 diabetes by 1.28 (95% CI, 1.21 to 1.35) times. Participants with all six risk alleles had an OR of 5.71 (95% CI, 1.15 to 28.3) compared to those with no risk alleles. The 8.1% of participants that were double-homozygous for the risk alleles at TCF7L2 and Pro12Ala had an OR of 3.16 (95% CI, 2.22 to 4.50), compared to 4.3% with no TCF7L2 risk alleles and either no or one Glu23Lys or Pro12Ala risk alleles.
Conclusions: Combining information from several known common risk polymorphisms allows the identification of population subgroups with markedly differing risks of developing type 2 diabetes compared to those obtained using single polymorphisms. This approach may have a role in future preventative measures for common, polygenic diseases.
Conflict of interest statement
Figures




Similar articles
-
Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians.Diabetes. 2010 Aug;59(8):2068-74. doi: 10.2337/db09-1386. Epub 2010 Apr 27. Diabetes. 2010. PMID: 20424228 Free PMC article.
-
[Risk of type 2 diabetes mellitus in the Kyrgyz population in the presence of ADIPOQ (G276T), KCNJ11 (Glu23Lys), TCF7L2 (IVS3C>T) gene polymorphisms].Ter Arkh. 2017;89(10):40-47. doi: 10.17116/terarkh2017891040-47. Ter Arkh. 2017. PMID: 29171469 Russian.
-
Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study.Scand J Clin Lab Invest. 2009;69(2):282-7. doi: 10.1080/00365510802538188. Scand J Clin Lab Invest. 2009. PMID: 18972257
-
Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis.BMC Med Genet. 2009 Feb 19;10:15. doi: 10.1186/1471-2350-10-15. BMC Med Genet. 2009. PMID: 19228405 Free PMC article. Review.
-
[Genetics of type 2 diabetes].Internist (Berl). 2005 Jul;46(7):741-2, 744-6, 748-9. doi: 10.1007/s00108-005-1434-5. Internist (Berl). 2005. PMID: 15912330 Review. German.
Cited by
-
Examining the impact of genetic testing for type 2 diabetes on health behaviors: study protocol for a randomized controlled trial.Trials. 2012 Aug 1;13:121. doi: 10.1186/1745-6215-13-121. Trials. 2012. PMID: 22852560 Free PMC article. Clinical Trial.
-
Translational Genomic Research: Protocol Development and Initial Outcomes following SNP Testing for Colon Cancer Risk.Transl Behav Med. 2013 Mar 1;3(1):17-29. doi: 10.1007/s13142-012-0149-0. Epub 2012 Jun 10. Transl Behav Med. 2013. PMID: 23565131 Free PMC article.
-
The TCF7L2 locus and type 1 diabetes.BMC Med Genet. 2007 Aug 3;8:51. doi: 10.1186/1471-2350-8-51. BMC Med Genet. 2007. PMID: 17683561 Free PMC article.
-
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study.BMC Med Genet. 2011 May 6;12:63. doi: 10.1186/1471-2350-12-63. BMC Med Genet. 2011. PMID: 21548950 Free PMC article.
-
Reclassification of genetic-based risk predictions as GWAS data accumulate.Genome Med. 2016 Feb 17;8(1):20. doi: 10.1186/s13073-016-0272-5. Genome Med. 2016. PMID: 26884246 Free PMC article.
References
-
- Edwards AO, Ritter R, 3rd, Abel KJ, Manning A, Panhuysen C, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421–424. - PubMed
-
- Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419–421. - PubMed
-
- Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet. 2001;17:502–510. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical